Chinese Journal of Dermatology ›› 2022, Vol. 55 ›› Issue (3): 276-279.doi: 10.35541/cjd.20200108
• Reviews • Previous Articles
Lyu Ling, Lyu Xiaoyan
Received:
2020-02-13
Revised:
2021-01-03
Online:
2022-03-15
Published:
2022-03-03
Contact:
Lyu Xiaoyan
E-mail:clazhou@126.com
Lyu Ling, Lyu Xiaoyan. Dermatomyositis with malignancy: an update[J]. Chinese Journal of Dermatology, 2022, 55(3): 276-279.doi:10.35541/cjd.20200108
[1] | Sontheimer RD. Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis siné myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness?[J]. J Am Acad Dermatol, 2002,46(4):626⁃636. doi: 10.1067/mjd.2002.120621. |
[2] | Yang Z, Lin F, Qin B, et al. Polymyositis/dermatomyositis and malignancy risk: a metaanalysis study[J]. J Rheumatol, 2015,42(2):282⁃291. doi: 10.3899/jrheum.140566. |
[3] | Tiniakou E, Mammen AL. Idiopathic inflammatory myopathies and malignancy: a comprehensive review[J]. Clin Rev Allergy Immunol, 2017,52(1):20⁃33. doi: 10.1007/s12016⁃015⁃8511⁃x. |
[4] | Pinal⁃Fernandez I, Ferrer⁃Fabregas B, Trallero⁃Araguas E, et al. Tumour TIF1 mutations and loss of heterozygosity related to cancer⁃associated myositis[J]. Rheumatology (Oxford), 2018,57(2):388⁃396. doi: 10.1093/rheumatology/kex413. |
[5] | 薛珂, 权晟, 赵茜, 等. 合并肺间质病变或恶性肿瘤皮肌炎患者的外周血差异基因表达分析[J]. 中华皮肤科杂志, 2020,53(1):23⁃29. doi: 10.35541/cjd.20190593. |
[6] | András C, Bodoki L, Nagy⁃Vincze M, et al. Retrospective analysis of cancer⁃associated myositis patients over the past 3 decades in a Hungarian myositis cohort[J]. Pathol Oncol Res, 2020,26(3):1749⁃1755. doi: 10.1007/s12253⁃019⁃00756⁃4. |
[7] | Morris P, Dare J. Juvenile dermatomyositis as a paraneoplastic phenomenon: an update[J]. J Pediatr Hematol Oncol, 2010,32(3):189⁃191. doi: 10.1097/MPH.0b013e3181bf29a2. |
[8] | Liu Y, Xu L, Wu H, et al. Characteristics and predictors of malignancy in dermatomyositis: analysis of 239 patients from northern China[J]. Oncol Lett, 2018,16(5):5960⁃5968. doi: 10.3892/ol.2018.9409. |
[9] | Leatham H, Schadt C, Chisolm S, et al. Evidence supports blind screening for internal malignancy in dermatomyositis: Data from 2 large US dermatology cohorts[J]. Medicine (Baltimore), 2018,97(2):e9639. doi: 10.1097/MD.0000000000009639. |
[10] | Qiang JK, Kim WB, Baibergenova A, et al. Risk of malignancy in dermatomyositis and polymyositis[J]. J Cutan Med Surg, 2017,21(2):131⁃136. doi: 10.1177/1203475416665601. |
[11] | Fang YF, Wu YJ, Kuo CF, et al. Malignancy in dermatomyositis and polymyositis: analysis of 192 patients[J]. Clin Rheumatol, 2016,35(8):1977⁃1984. doi: 10.1007/s10067⁃016⁃3296⁃8. |
[12] | Best M, Jachiet M, Molinari N, et al. Distinctive cutaneous and systemic features associated with specific antimyositis antibodies in adults with dermatomyositis: a prospective multicentric study of 117 patients[J]. J Eur Acad Dermatol Venereol, 2018,32(7):1164⁃1172. doi: 10.1111/jdv.14759. |
[13] | Mainetti C, Terziroli Beretta⁃Piccoli B, Selmi C. Cutaneous manifestations of dermatomyositis: a comprehensive review[J]. Clin Rev Allergy Immunol, 2017,53(3):337⁃356. doi: 10.1007/s12016⁃017⁃8652⁃1. |
[14] | Hendren E, Vinik O, Faragalla H, et al. Breast cancer and dermatomyositis: a case study and literature review[J]. Curr Oncol, 2017,24(5):e429⁃e433. doi: 10.3747/co.24.3696. |
[15] | Ahuja S, Makkar P, Gupta S, et al. Paraneoplastic syndrome and underlying breast cancer: a worsening rash despite initiation of chemotherapy[J]. J Community Support Oncol, 2016,14(5):229⁃231. doi: 10.12788/jcso.0186. |
[16] | Venalis P, Selickaja S, Lundberg K, et al. Association of anti⁃transcription intermediary factor 1γ antibodies with paraneoplastic rheumatic syndromes other than dermatomyositis[J]. Arthritis Care Res (Hoboken), 2018,70(4):648⁃651. doi: 10.1002/acr.23325. |
[17] | Targoff IN, Mamyrova G, Trieu EP, et al. A novel autoantibody to a 155⁃kd protein is associated with dermatomyositis[J]. Arthritis Rheum, 2006,54(11):3682⁃3689. doi: 10.1002/art.22164. |
[18] | Trallero⁃Araguás E, Rodrigo⁃Pendás JÁ, Selva⁃O′Callaghan A, et al. Usefulness of anti⁃p155 autoantibody for diagnosing cancer⁃associated dermatomyositis: a systematic review and meta⁃analysis[J]. Arthritis Rheum, 2012,64(2):523⁃532. doi: 10.1002/ art.33379. |
[19] | Fujimoto M, Watanabe R, Ishitsuka Y, et al. Recent advances in dermatomyositis⁃specific autoantibodies[J]. Curr Opin Rheumatol, 2016,28(6):636⁃644. doi: 10.1097/BOR.0000000000000329. |
[20] | Albayda J, Pinal⁃Fernandez I, Huang W, et al. Antinuclear matrix protein 2 autoantibodies and edema, muscle disease, and malignancy risk in dermatomyositis patients. Arthritis Care Res (Hoboken), 2017, 69(11):1771⁃1776. doi: 10.1002/acr.23188. |
[21] | Rider LG, Nistala K. The juvenile idiopathic inflammatory myopathies: pathogenesis, clinical and autoantibody phenotypes, and outcomes[J]. J Intern Med, 2016,280(1):24⁃38. doi: 10. 1111/joim.12444. |
[22] | Love LA, Leff RL, Fraser DD, et al. A new approach to the classification of idiopathic inflammatory myopathy: myositis⁃specific autoantibodies define useful homogeneous patient groups[J]. Medicine (Baltimore), 1991,70(6):360⁃374. doi: 10.1097/00005792⁃199111000⁃00002. |
[23] | Hengstman GJ, Vree Egberts WT, Seelig HP, et al. Clinical characteristics of patients with myositis and autoantibodies to different fragments of the Mi⁃2 beta antigen[J]. Ann Rheum Dis, 2006,65(2):242⁃245. doi: 10.1136/ard.2005.040717. |
[24] | Yang H, Peng Q, Yin L, et al. Identification of multiple cancer⁃associated myositis⁃specific autoantibodies in idiopathic inflammatory myopathies: a large longitudinal cohort study[J]. Arthritis Res Ther, 2017,19(1):259. doi: 10.1186/s13075⁃017⁃1469⁃8. |
[25] | Yang Z, Lin F, Qin B, et al. Polymyositis/dermatomyositis and malignancy risk: a metaanalysis study[J]. J Rheumatol, 2015,42(2):282⁃291. doi: 10.3899/jrheum.140566. |
[26] | Dobloug GC, Garen T, Brunborg C, et al. Survival and cancer risk in an unselected and complete Norwegian idiopathic inflammatory myopathy cohort[J]. Semin Arthritis Rheum, 2015,45(3):301⁃308. doi: 10.1016/j.semarthrit.2015.06.005. |
[27] | Limaye V, Luke C, Tucker G, et al. The incidence and associations of malignancy in a large cohort of patients with biopsy⁃determined idiopathic inflammatory myositis[J]. Rheumatol Int, 2013,33(4):965⁃971. doi: 10.1007/s00296⁃012⁃2489⁃y. |
[28] | Tiniakou E, Pinal⁃Fernandez I, Lloyd TE, et al. More severe disease and slower recovery in younger patients with anti⁃3⁃hydroxy⁃3⁃methylglutaryl⁃coenzyme A reductase⁃associated autoimmune myopathy. Rheumatology (Oxford), 2017,56(5):787⁃794. doi: 10.1093/rheumatology/kew470. |
[29] | Selva⁃O′Callaghan A, Grau JM, Gámez⁃Cenzano C, et al. Conventional cancer screening versus PET/CT in dermatomyositis/ polymyositis[J]. Am J Med, 2010,123(6):558⁃562. doi: 10.1016/ j.amjmed.2009.11.012. |
[30] | Titulaer MJ, Soffietti R, Dalmau J, et al. Screening for tumours in paraneoplastic syndromes: report of an EFNS task force[J]. Eur J Neurol, 2011,18(1):19⁃e3. doi: 10.1111/j.1468⁃1331.2010. 03220.x. |
[1] | Yue Chao, Duan Mengying, Wang Tao, Zhang Manyu, Dai Yeqin, Peng Jianzhong, Song Xiuzu. Application of the upper eyelid orbicularis oculi myocutaneous island flap in repairing secondary defects after resection of eyelid and periorbital skin tumors: a retrospective analysis of 28 cases [J]. Chinese Journal of Dermatology, 2023, 56(9): 862-865. |
[2] | Wang Yuqian, Qiao Jianjun, Fang Hong. Comparison of the latest Chinese and international guidelines/consensus on diagnosis and treatment of alopecia areata [J]. Chinese Journal of Dermatology, 2023, 56(9): 885-888. |
[3] | Yuan Xingang, Ni Sili, Zhang Jian, Luo Xiaoyan, Wang Hua. Improving diagnosis and treatment of melanocytic nevi in children: an urgent need [J]. Chinese Journal of Dermatology, 2023, 56(8): 782-786. |
[4] | Committee on Psoriasis, Chinese Society of Dermatology. Guideline for the diagnosis and treatment of psoriasis in China (2023 edition) [J]. Chinese Journal of Dermatology, 2023, 56(7): 573-625. |
[5] | Chen Qiquan, Yang Xianjie, Wang Wenwen, Liang Gaopeng, Song Zhiqiang . Development and application of clinical assessment tools for cholinergic urticaria [J]. Chinese Journal of Dermatology, 2023, 56(6): 563-566. |
[6] | Mi Shuhong, Yu Yanqin, Hao Jinqi, Li Wei, Zhang Yang, Jia Ximei, Huang Yuxian, Sun Huaiyu, Shi Jihai. Analysis of imaging characteristics of papulopustular rosacea by high-frequency ultrasound combined with color Doppler flow imaging [J]. Chinese Journal of Dermatology, 2023, 56(6): 540-544. |
[7] | Liang Yunsheng, Li Zhanhong, Wu Yibei. Progress in the treatment of chronic spontaneous urticaria: insights from the changes in the understanding of its pathogenesis [J]. Chinese Journal of Dermatology, 2023, 56(6): 552-558. |
[8] | Chen Qiquan, Yang Xianjie, Gu Heng, Xu Jinhua, Hao Fei, Yao Xu, Song Zhiqiang. Construction of “Expert consensus on diagnosis and treatment of chronic inducible urticaria in China (2023)” based on the Delphi method [J]. Chinese Journal of Dermatology, 2023, 56(6): 534-539. |
[9] | Immunology Group, Chinese Society of Dermatology. Expert consensus on diagnosis and treatment of chronic inducible urticaria in China (2023) [J]. Chinese Journal of Dermatology, 2023, 56(6): 479-488. |
[10] | Hu Qingjie, Zhou Min, Yao Xu. Analysis of clinical characteristics of 36 patients with pyoderma gangrenosum and comparison between the PARACELSUS score and Delphi criteria for their diagnosis [J]. Chinese Journal of Dermatology, 2023, 56(5): 410-414. |
[11] | Committee on Sexually Transmitted Diseases, China Dermatologist Association. Expert consensus on clinical management of serofast state in syphilis (2023) [J]. Chinese Journal of Dermatology, 2023, 56(5): 383-388. |
[12] | Jia Weixue, Li Chengrang. Comparison of Chinese and international guidelines and consensus for the diagnosis and treatment of vitiligo [J]. Chinese Journal of Dermatology, 2023, 56(5): 471-475. |
[13] | Wang Min, He Pingxiu, Cheng Lifang, Hong Kechun, Ai Yong. A case of meningothelial hamartoma of the scalp [J]. Chinese Journal of Dermatology, 2023, 56(5): 449-450. |
[14] | Jiao Xiaoyan, Yin Guangwen, Li Dongqin, Yin Yakun, Cai Bingjie, Fang Hui. A clinical analysis of 74 cases of bullous pemphigoid with stroke [J]. Chinese Journal of Dermatology, 2023, 56(4): 330-334. |
[15] | Lian Panpan, Liu Jun, Su Zhonglan, Wang Hongwei. Effect of peroxisome proliferator-activated receptor γ on skin physiological and pathological processes [J]. Chinese Journal of Dermatology, 2023, 56(4): 365-368. |
|